Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”

被引：0

作者：

Michele R. Wilson

Matt Wasserman

Taj Jadavji

Maarten Postma

Marie-Claude Breton

Francois Peloquin

Stephanie R. Earnshaw

Cheryl McDade

Heather L. Sings

Raymond Farkouh

机构：

[1] RTI Health Solutions,Departments of Pediatrics, Microbiology, Immunology, and Infectious Diseases, Faculty of Medicine, Cumming School of Medicine

[2] Pfizer Inc.,Department of Pharmacy

[3] University of Calgary,Research Institute of Science in Healthy Aging and healthcaRE (SHARE)

[4] University of Groningen,undefined

[5] University of Groningen,undefined

[6] University Medical Center Groningen (UMCG),undefined

[7] Pfizer Canada Inc.,undefined

[8] Pfizer Inc.,undefined

来源：

Infectious Diseases and Therapy | 2018年 / 7卷

关键词：

Cost-effectiveness; Health economics; Pneumococcal disease; Vaccination;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：539 / 543

页数：4

共 50 条

[41] Response to Eriksson et al A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients
Dawson, Rachel Souza
Feemster, Kristen
McIntosh, E. David G.
Buchwald, Ulrike K.
TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (02)
[42] Response to Gomez et al.'s Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants"
Perdrizet, Johnna
Horn, Emily
Nua, Winniefer
Perez-Peralta, Judith
Nailes, Jennifer
Santos, Jaime
Ong-Lim, Anna
INFECTIOUS DISEASES AND THERAPY, 2022, 11 (04) : 1763 - 1765
[43] Response to Gomez et al.’s Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”
Johnna Perdrizet
Emily Horn
Winniefer Nua
Judith Perez-Peralta
Jennifer Nailes
Jaime Santos
Anna Ong-Lim
Infectious Diseases and Therapy, 2022, 11 : 1763 - 1765
[44] ECONOMIC IMPACT IN DOMINICAN REPUBLIC SENASA OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) VERSUS NO VACCINATION IN OLDER ADULTS
Del Villar-Tapia, Y.
Brito-Tayson, G.
Lizardo, J.
VALUE IN HEALTH, 2020, 23 : S173 - S173
[45] Comment on "Vila-Corcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016."
Gessner, Bradford D.
Theilacker, Christian
Mendez, Cristina
Jodar, Luis
VACCINE, 2021, 39 (30) : 4032 - 4033
[46] SEVEN, TEN OR THIRTEEN? THE COST-UTILITY OF INFANT VACCINATION WITH A 7-, 10-OR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN THE NETHERLANDS
Vemer, P.
de Greeff, S. C. D.
Schouls, L. M.
Al, M. J.
de Melker, H. D.
VALUE IN HEALTH, 2009, 12 (07) : A228 - A228
[47] ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) VERSUS NO VACCINATION IN ADULTS >60 YEARS, IN COSTA RICAN SOCIAL SECURITY
Chaverri, J.
Castro, J.
VALUE IN HEALTH, 2020, 23 : S171 - S171
[48] A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand
Lijoy Varghese
Louise Talbot
Andrea Govender
Xu-Hao Zhang
Bruce A. Mungall
Applied Health Economics and Health Policy, 2018, 16 : 331 - 345
[49] A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand
Varghese, Lijoy
Talbot, Louise
Govender, Andrea
Zhang, Xu-Hao
Mungall, Bruce A.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (03) : 331 - 345
[50] Epidemiology and Population Structure of Serotypes 1, 5 and 7F Carried by Children in Portugal from 1996-2010 before Introduction of the 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines
Almeida, Sonia T.
de Lencastre, Herminia
Sa-Leao, Raquel
PLOS ONE, 2013, 8 (09):

← 1 2 3 4 5 →